|
|
səhifə | 9/11 | tarix | 02.01.2022 | ölçüsü | 3,28 Mb. | | #1626 |
|
Strength of recommendation Strong: - Benefits clearly > risks and burden OR risks and burden clearly > benefits
Weak: - Benefits finely balanced with risks and burden
Insufficient:
Continuous arrivals of new drugs on the market1 Older formulations unavailable in European formularies2
Dostları ilə paylaş:
|
|
|